+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Meningitis Diagnostic Testing Market

  • PDF Icon

    Report

  • 117 Pages
  • December 2022
  • Region: Global
  • Polaris Market Research
  • ID: 5724149
The global meningitis diagnostic testing market size is expected to reach USD 162.62 million by 2032, according to a new study. The report “Meningitis Diagnostic Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (Latex Agglutination Test, Lateral Flow Assay, PCR Assay, ELISA Test, Culture Test); By End-use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Key factors influencing the market growth rise in the cases of meningitis in developed economies, upsurge in diagnostic centers, and patient’s awareness regarding the severity of the disease. Moreover, emerging nations with viable options for treatment and a massive target population contribute to market growth. In line with this, in January 2021, Thermo Fisher Scientific signed a final agreement to buy Mesa Biotech, Inc., a privately held molecular diagnostic firm, for about $450 million to provide reliable testing solutions.

Around 375 instances of meningococcal infection were recorded in the U.S. In June 2021, according to the Center for Disease Control and Prevention Updates (an incidence rate of 0.11 cases per 100,000 persons). All these factors cumulatively affect the industry growth of this region in the forecast period.

Asia Pacific region is estimated to show the fastest growth rate in the forecast period for some key reasons, including the increasing prevalence of meningitis, continuous research initiatives, and developing economies. Additionally, continuing trials in the region, favorable regulatory efforts, and increased investments by regional market participants are expected to boost regional growth throughout the forecast period.

In June 2022, the Florida Department of Health and the Centers for Disease Control and Prevention (CDC) worked together to discover one of the worst meningococcal disease outbreaks among homosexual and bisexual men in American history. There have been at least 24 cases and six fatalities among homosexual and bisexual males recorded till that time. These outbreaks boosted the market’s growth. The development of diagnostic tests which can detect meningitis in less time provides additional help in treating meningitis, leading to the growth of this industry.

Meningitis Diagnostic Testing Market Report Highlights

  • PCR Assay segment is anticipated to grow at the highest CAGR over the forecast period due to its rapid test findings that are highly exact and accurate; it has the most significant market revenue. This fast turnaround for results improved clinical outcomes for patient care.
  • The hospital sector is expected to hold a significant market share over the forecast period due to the availability of optimal care delivery and the severity of meningitis in patients.
  • North America is expected to grow significantly over the projected period because of an increase in the number of patients suffering from the disease.
  • Key players in the market include Thermo Fisher Scientific, Bio-Rad Laboratories, ELI TechGroup, Abbott Laboratories, Becton and Dickinson, Luminex Corporation, GlaxoSmithKline, Merck KGaA, Baxter Quest Diagnostics, Roche, Cepheid, Pfizer.

The publisher has segmented the meningitis diagnostic testing market report based on test type, end-use, and region:

Meningitis Diagnostic Testing, Test Types Outlook (Revenue - USD Million, 2019 - 2032)

  • Latex Agglutination Test
  • Lateral Flow Assay
  • PCR Assay
  • ELISA Test
  • Culture Test

Meningitis Diagnostic Testing, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Diagnostic Centers
  • Others

Meningitis Diagnostic Testing, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Frequently Asked Questions about the Meningitis Diagnostic Testing Market

What is the estimated value of the Meningitis Diagnostic Testing Market?

The Meningitis Diagnostic Testing Market was estimated to be valued at $119.22 million in 2023.

What is the growth rate of the Meningitis Diagnostic Testing Market?

The growth rate of the Meningitis Diagnostic Testing Market is 3.5%, with an estimated value of $162.62 million by 2032.

What is the forecasted size of the Meningitis Diagnostic Testing Market?

The Meningitis Diagnostic Testing Market is estimated to be worth $162.62 million by 2032.

Who are the key companies in the Meningitis Diagnostic Testing Market?

Key companies in the Meningitis Diagnostic Testing Market include Thermo Fisher Scientific Inc., Bio, Rad Laboratories Inc., ELITechGroup, Abbott Laboratories, Becton Dickinson and Company, Luminex Corporation, GlaxoSmithKline plc and Baxter Quest Diagnostics Inc..

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Global Meningitis Diagnostic Testing Market Insights
4.1. Meningitis Diagnostic Testing Market - Industry Snapshot
4.2. Meningitis Diagnostic Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing prevalence of meningitis
4.2.1.2. Rise in demand for rapid diagnosis by using innovative technologies
4.2.2. Restraints and Challenges
4.2.2.1. Stringent regulatory framework
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Meningitis Diagnostic Testing Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Meningitis Diagnostic Testing Market, by Test Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Meningitis Diagnostic Testing, by Test Type, 2019-2032 (USD Million)
5.3. Latex Agglutination Tests
5.3.1. Global Meningitis Diagnostic Testing Market, by Latex Agglutination Tests, by Region, 2019-2032 (USD Million)
5.4. Lateral Flow Assay
5.4.1. Global Meningitis Diagnostic Testing Market, by Lateral Flow Assay, by Region, 2019-2032 (USD Million)
5.5. PCR Assay
5.5.1. Global Meningitis Diagnostic Testing Market, by PCR Assay, by Region, 2019-2032 (USD Million)
5.6. ELISA Tests
5.6.1. Global Meningitis Diagnostic Testing Market, by ELISA Tests, by Region, 2019-2032 (USD Million)
5.7. Culture Tests
5.7.1. Global Meningitis Diagnostic Testing Market, by Culture Tests, by Region, 2019-2032 (USD Million)

6. Global Meningitis Diagnostic Testing Market, by End-Use
6.1. Key Findings
6.2. Introduction
6.2.1. Global Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
6.3. Hospitals
6.3.1. Global Meningitis Diagnostic Testing Market, by Hospitals, by Region, 2019-2032 (USD Million)
6.4. Diagnostic Centers
6.4.1. Global Meningitis Diagnostic Testing Market, by Diagnostic Centers, by Region, 2019-2032 (USD Million)
6.5. Others
6.5.1. Global Meningitis Diagnostic Testing Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Meningitis Diagnostic Testing Market, by Geography
7.1. Key findings
7.2. Introduction
7.2.1. Meningitis Diagnostic Testing Market Assessment, By Geography, 2019-2032 (USD Million)
7.3. Meningitis Diagnostic Testing Market - North America
7.3.1. North America: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.3.2. North America: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.3.3. Meningitis Diagnostic Testing Market - U.S.
7.3.3.1. U.S.: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.3.3.2. U.S.: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.3.4. Meningitis Diagnostic Testing Market - Canada
7.3.4.1. Canada: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.3.4.2. Canada: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.4. Meningitis Diagnostic Testing Market - Europe
7.4.1. Europe: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.4.2. Europe: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.4.3. Meningitis Diagnostic Testing Market - UK
7.4.3.1. UK: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.4.3.2. UK: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.4.4. Meningitis Diagnostic Testing Market - France
7.4.4.1. France: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.4.4.2. France: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.4.5. Meningitis Diagnostic Testing Market - Germany
7.4.5.1. Germany: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.4.5.2. Germany: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.4.6. Meningitis Diagnostic Testing Market - Italy
7.4.6.1. Italy: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.4.6.2. Italy: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.4.7. Meningitis Diagnostic Testing Market - Spain
7.4.7.1. Spain: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.4.7.2. Spain: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.4.8. Meningitis Diagnostic Testing Market - Netherlands
7.4.8.1. Netherlands: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.4.8.2. Netherlands: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.4.9. Meningitis Diagnostic Testing Market - Russia
7.4.9.1. Russia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.4.9.2. Russia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.5. Meningitis Diagnostic Testing Market - Asia Pacific
7.5.1. Asia Pacific: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.5.2. Asia Pacific: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.5.3. Meningitis Diagnostic Testing Market - China
7.5.3.1. China: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.5.3.2. China: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.5.4. Meningitis Diagnostic Testing Market - India
7.5.4.1. India: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.5.4.2. India: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.5.5. Meningitis Diagnostic Testing Market - Malaysia
7.5.5.1. Malaysia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.5.5.2. Malaysia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.5.6. Meningitis Diagnostic Testing Market - Japan
7.5.6.1. Japan: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.5.6.2. Japan: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.5.7. Meningitis Diagnostic Testing Market - Indonesia
7.5.7.1. Indonesia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.5.7.2. Indonesia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.5.8. Meningitis Diagnostic Testing Market - South Korea
7.5.8.1. South Korea: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.5.8.2. South Korea: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.6. Meningitis Diagnostic Testing Market - Middle East & Africa
7.6.1. Middle East & Africa: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.6.2. Middle East & Africa: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.6.3. Meningitis Diagnostic Testing Market - Saudi Arabia
7.6.3.1. Saudi Arabia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.6.3.2. Saudi Arabia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.6.4. Meningitis Diagnostic Testing Market - UAE
7.6.4.1. UAE: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.6.4.2. UAE: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.6.5. Meningitis Diagnostic Testing Market - Israel
7.6.5.1. Israel: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.6.5.2. Israel: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.6.6. Meningitis Diagnostic Testing Market - South Africa
7.6.6.1. South Africa: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.6.6.2. South Africa: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.7. Meningitis Diagnostic Testing Market - Latin America
7.7.1. Latin America: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.7.2. Latin America: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.7.3. Meningitis Diagnostic Testing Market - Mexico
7.7.3.1. Mexico: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.7.3.2. Mexico: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.7.4. Meningitis Diagnostic Testing Market - Brazil
7.7.4.1. Brazil: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.7.4.2. Brazil: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
7.7.5. Meningitis Diagnostic Testing Market - Argentina
7.7.5.1. Argentina: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
7.7.5.2. Argentina: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)

8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles
9.1. Thermo Fisher Scientific
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. Bio-Rad Laboratories
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. ELITech Group
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Abbott Laboratories
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. Becton
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. Dickinson and Company
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Luminex Corporation
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. GlaxoSmithKline
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. Merck KGaA
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. Baxter Quest Diagnostics
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
9.11. F. Hoffman-La Roche
9.11.1. Company Overview
9.11.2. Financial PerTest Typeance
9.11.3. Product Benchmarking
9.11.4. Recent Development
9.12. Cepheid
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Recent Development
9.13. Pfizer
9.13.1. Company Overview
9.13.2. Financial Performance
9.13.3. Product Benchmarking
9.13.4. Recent Development

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • ELITechGroup
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Luminex Corporation
  • GlaxoSmithKline plc
  • Merck KGaA
  • Baxter Quest Diagnostics Inc.
  • F. Hoffman-La Roche Ltd.
  • Cepheid
  • Pfizer Inc.